“In silico docking studies of RP2 (X-Linked retinitis pigmentosa) protein using anthocyanins as potential inhibitors” (2013) Bangladesh Journal of Pharmacology, 8(3), pp. 292–299. doi:10.3329/bjp.v8i3.15110.